SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-033331
Filing Date
2019-06-03
Accepted
2019-06-03 09:00:49
Documents
9
Period of Report
2019-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-10954_18k.htm 8-K 49317
2 EX-4.1 a19-10954_1ex4d1.htm EX-4.1 55758
3 EX-4.2 a19-10954_1ex4d2.htm EX-4.2 61035
4 EX-10.1 a19-10954_1ex10d1.htm EX-10.1 56419
5 EX-10.2 a19-10954_1ex10d2.htm EX-10.2 111642
6 EX-10.3 a19-10954_1ex10d3.htm EX-10.3 91943
7 EX-10.4 a19-10954_1ex10d4.htm EX-10.4 90573
8 EX-99.1 a19-10954_1ex99d1.htm EX-99.1 11511
9 GRAPHIC g109541mmi001.jpg GRAPHIC 3446
  Complete submission text file 0001104659-19-033331.txt   534529
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 19872274
SIC: 2834 Pharmaceutical Preparations